Ferty9 Fertility Center

Ferty9 Fertility Center

Type	Private (subsidiary)
ISIN	🆔
Industry	Healthcare — assisted reproductive technology (ART)
Founded 📆	December 2013
Founders 👔	Dr. C. Jyothi Budi and four partner physicians
Headquarters 🏙️	, Hyderabad , India
Area served 🗺️	Telangana and Andhra Pradesh, India
Key people	Dr. C. Jyothi Budi (Medical Director); Vinesh Gadhia (Chief Executive Officer and Executive Director, since April 2023)
Services	In vitro fertilization (IVF), intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), gamete cryopreservation, male infertility diagnostics and treatment
Owner	Verlinvest (controlling stake, since April 2023)
Members
Number of employees
🌐 Website	[ ]
📇 Address
📞 telephone

Ferty9 Fertility Center is a chain of assisted reproductive technology (ART) clinics headquartered in Hyderabad, Telangana, India. It is operated under the registered legal entity Star Fertility Private Limited. The chain was established in December 2013 in Secunderabad by a group of five physicians led by Dr. C. Jyothi Budi, and provides fertility diagnostics and treatment across the Telangana and Andhra Pradesh regions. In April 2023, the Brussels-based investment firm Verlinvest acquired a controlling stake in the company for approximately US$50 million, its first healthcare investment in India.

History

Ferty9 was founded in December 2013 in Secunderabad by Dr. C. Jyothi Budi together with four partner physicians, initially operating as a small group of fertility clinics in the Hyderabad area. Over the following decade the chain expanded its clinic network across the Telangana and Andhra Pradesh regions; by the time of its 2023 acquisition it operated seven centers in the two states.

On 19 April 2023, Verlinvest - an investment firm founded by the families that control the brewing company AB InBev - announced the acquisition of a controlling stake in Ferty9 for an investment of roughly US$50 million, describing the transaction as its first investment in the Indian healthcare sector. Lincoln International served as financial advisor on the deal. As part of the transaction, Verlinvest appointed fertility-sector executive Vinesh Gadhia as Chief Executive Officer and Executive Director of the company's board, with a stated intent to expand the chain's footprint through both organic growth and acquisition of additional fertility clinics in India. Dr. C. Jyothi Budi has continued in the role of Medical Director following the acquisition, according to the company's own published materials.

As of the mid-2020s, the company reports operating eleven clinics across Andhra Pradesh and Telangana.

Clinical Services and Specializations

Ferty9's clinics offer the following categories of fertility diagnostics and treatment:

• In vitro fertilization (IVF)

• Intrauterine insemination (IUI)

• Intracytoplasmic sperm injection (ICSI)

• Egg and sperm cryopreservation (gamete banking)

• Diagnosis and treatment of male infertility

• Ancillary techniques such as laser-assisted hatching and physiological ICSI (PICSI)

Individual clinics are described as staffed with reproductive medicine specialists, embryologists, and patient counselors.

Geographical Presence

Ferty9's headquarters and largest concentration of clinics are located in and around Hyderabad, Telangana, with locations reported in Kukatpally, LB Nagar, Secunderabad (West Marredpally), and Banjara Hills. Additional locations have been reported in Karimnagar, Warangal, and Rajahmundry, Vijayawada, Visakhapatnam, and Tirupati in Andhra Pradesh. The company's LinkedIn profile additionally lists a location in Madhapur (Cyberabad) and Dilsukhnagar. As of 2023 reporting around the Verlinvest transaction, the network was described as comprising seven centers across the Telangana and Andhra Pradesh region; more recent branch counts are sourced only to the company's own website, as noted above.

Regulatory Framework

Fertility clinics in India, including ART chains such as Ferty9, operate within a regulatory structure established by the Indian Council of Medical Research (ICMR) and, since 2021, by national legislation. The Assisted Reproductive Technology (Regulation) Act, 2021, enacted by the Government of India, requires ART clinics and banks to register with a National Registry of ART Clinics and Banks and establishes standards for patient consent, gamete handling, and clinic operation. The Act builds on earlier ICMR National Guidelines for Accreditation, Supervision, and Regulation of ART Clinics, first issued in 2005.

Ferty9's own published material references such accreditations as general criteria patients should look for when selecting a fertility clinic, without stating that Ferty9 itself holds specific certifications from these bodies.

Ownership and Corporate Structure

Ferty9 operates under the legal entity Star Fertility Private Limited. Following the April 2023 transaction, Verlinvest holds a controlling stake in the company, with Dr. C. Jyothi Budi and her original co-founding partners retaining a minority interest, according to deal coverage at the time. One data aggregator reports revenue of approximately ₹135 crore for the year ending March 2025, and employee counts ranging from roughly 290 to over 500 across different profile snapshots.

See also

• Assisted reproductive technology
• In vitro fertilization
• Fertility clinic
• Healthcare in India

References

This article "Ferty9 Fertility Center" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Ferty9 Fertility Center. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

---